Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).
Sign Up to like & getrecommendations! Published in 2020 at "Joint bone spine"
DOI: 10.1016/j.jbspin.2020.02.009
Abstract: OBJECTIVE To assess why patients choose TNF- versus non-TNF biologics for treating active rheumatoid arthritis (RA) after methotrexate-failure. METHODS Participants responded to the question "What sort of things help a patient decide the treatment choice… read more here.
Keywords: tnf; active rheumatoid; tnf biologic; non tnf ... See more keywords